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Available online 10 March 2017One of the goals for the development of more effective cancer therapies with reduced toxic side effects is the op-
timization of innovative treatments to selectively kill tumor cells. The use of nanovectors loaded with targeted
therapeutic payloads is one of themost investigated strategies. In this paper superparamagnetic iron oxide nano-
particles (SPIONs) coated by a silica shell or uncoated, were functionalized with single-layer and bi-layer conju-
gated linoleic acid (CLA). Silica was used to protect the magnetic core from oxidation, improve the stability of
SPIONs and tailor their surface reactivity. CLA was used as novel grafting biomolecule for its anti-tumor activity
and to improve particle dispersibility. Mouse breast cancer 4T1 cells were treated with these different SPIONs.
SPIONs functionalized with the highest quantity of CLA and coatedwith silica shell were themost dispersed. Cell
viabilitywas reduced by SPIONs functionalizedwith CLA in comparisonwith cells whichwere untreated or treat-
edwith SPIONswithout CLA. As regards the types of SPIONs functionalizedwith CLA, the lowest viability was ob-
served in cells treated with uncoated SPIONs with the highest quantity of CLA.
In conclusion, the silica shell free SPIONs functionalizedwith the highest amount of CLA can be suggested as ther-
apeutic carriers because they have the best dispersion and ability to decrease 4T1 cell viability.
© 2017 Elsevier B.V. All rights reserved.1. Introduction
Some progress has beenmade in the field of anticancer therapies, al-
though the research on new strategies to find even more effective ther-
apies and to reduce their toxic side effects is still needed. The
development of innovative treatments to kill tumor or metastatic cells
is a challenging goal and for this reason, several possible approaches
are under investigation. Today nanomedicine-based therapies are used
in cancer research because they can bypass cancer cell multi-drug resis-
tance, poor solubility of hydrophobic anti-cancer drugs, and the use ofSciences, University "Amedeo
a, Italy.
marta.miola@polito.it
ggiora@unito.it (M. Maggiora),
asalute.to.it (M.P. Puccinelli),
(R.A. Canuto),
iupo.it (A. Follenzi).dangerous radiations [1]. Cancer nanomedicine pays particular atten-
tion to superparamagnetic iron oxide nanoparticles (SPIONs), that can
reach the tumor sites carrying chemotherapeutic drugs, nucleic acids,
monoclonal antibodies, viral vectors engineered with therapeutic sui-
cide genes or shRNAs [1,2,3]. SPIONs are also used for diagnostic assays,
generation of local hyperthermia for tumor therapy or tissue repair by
delivering stemcells [4,5]. In fact, SPIONs can be combinedwith contrast
fluorescent agents to improve cancer cell imaging [1]. In hyperthermia
therapy, SPIONs are localized near the cancer site by magnetic driving
and can induce localized heating by an external alternating magnetic
field. For example in “in vitro” experiments, 14 nm magnetic
nanoclusters killed about 74% of MCF-7 cancer cells, by applying tem-
perature of 45 °C for 1 h [6]. Similarly, a temperature of 43 °C for
about 17 min reduced the viability of HeLa cells exposed to an alternat-
ing magnetic field in the presence of silica coated iron oxide nanoparti-
cles (NPs) [7]. SPIONs can be internalized in humanmesenchymal stem
cells without affecting viability and structure. Following this, the SPION-
loaded stem cells can be attracted to specific sites by applying an exter-
nal magnetic field [8].
Table 1
Name and composition of the samples.
Acronym NPs Washing CLA CLA [μl] per 1 ml
of NPs suspension
Fe3O4 + CLA1 Fe3O4 Yes one-step 3.0
Fe3O4-NW+ CLA1 Fe3O4 No one-step 3.0
Fe3O4 + CLA1-TS Fe3O4 Yes two-step 3.0
Fe3O4-NW+ CLA1-TS Fe3O4 No two-step 3.0
Fe3O4 + CLA2 Fe3O4 Yes one-step 4.5
Fe3O4-SiO2 + CLA2 Fe3O4-SiO2 Yes one-step 4.5
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agents it is important to control their size, shape and surface properties,
in order to assure their stability in solution and maintain super-
paramagnetic properties also in the presence of a variety of molecules.
SPIONs which are smaller than 100 nm can easily circulate in the
blood without being captured by reticulo-endothelial cells and can
therefore selectively accumulate in the tumor microenvironment [3].
On the contrary unmodified SPIONs tend to aggregate into large clusters
and several studies suggest surface modification to avoid NP aggrega-
tion. A widely explored solution is surface coverage by polymers that
has the unavoidable disadvantage of causing an increase in particle
size and a potential loss in magnetic response [1]. Alternatively, small
intermediary molecules can be used, acting as stabilizing agents and
for the subsequent coupling of functional molecules. Fatty acids, in par-
ticular oleic acid (OA), have been used as capping agent to obtainmono-
disperse SPIONs suspensions [9].
This study aimed to prepare functionalized SPIONs able to affect
tumor cell viability. SPIONs, either coated with silica shell or uncoated,
were prepared and functionalized with conjugated linoleic acid (CLA)
in single- and bi-layer configuration. Silicawas used for its ability to pro-
tect themagnetic core from oxidation, to improve the magnetite stabil-
ity and to tailor the surface reactivity by improving biomolecule grafting
[10]. CLA was chosen to improve SPION dispersion and to add an anti-
cancer potential [11–13]. Fatty acids are crucial structural and function-
al cell components, and contribute to the functional/physical/chemical
features of membranes [11–13]. Concerning cancer, it is well known
that carcinogenesis is characterized by changes in fatty acid composi-
tion of membrane phospholipids.
2. Materials and methods
2.1. Synthesis of superparamagnetic iron-oxide nanoparticles (Fe3O4)
Among the differentmethods for the SPIONs production, the co-pre-
cipitation processwas selected since it is simple, rapid and allows a high
yield. An aqueous solution of Fe2+ and Fe3+ salts in a 1:2 M ratio was
prepared by mixing FeCl2 ∗ 4H2O and FeCl3 ∗ 6H2O in bi-distilled
water; subsequently the mixture was mechanically mixed at 300 rpm
and Fe3O4 precipitation occurred by adding NH4OH drop by drop, until
the pH of the mixture reached about 10. The suspension was put in ul-
trasound for 20 min; subsequently an aliquot was washed twice with
bi-distilled water to remove the unreacted reagents (Fe3O4), while the
other aliquot was not washed (Fe3O4-NW).
2.2. One-step synthesis of conjugated linoleic acid-capped Fe3O4
In this procedure conjugated linoleic acid (CLA) was added in a
single-step to the NP suspensions. A first synthesis of CLA-capped
Fe3O4 NPs was carried out by adding drop by drop 3.0 μl of CLA/ml
of NP suspension, to both washed (Fe3O4 + CLA1) or not washed
(Fe3O4-NW+CLA1), NP under mechanicalmixing. A second synthesis
(Fe3O4 + CLA2) was performed using a higher amount of CLA (4.5 μl
CLA/ml of NPs suspension). All suspensions were heated at 80 °C with
stirring at 150 rpm for half hour. At the end of the functionalization pro-
cess NP suspensionswerewashed twicewith ethanol and re-suspended
in bi-distilled water.
2.3. Two-step synthesis of conjugated linoleic acid-capped Fe3O4
In this procedure CLAwas added in two steps to the NP suspensions.
The two-step CLA-capped Fe3O4 NPs were synthesized by adding, in a
second step, a further aliquot of CLA (3.0 μl CLA/ml of NP suspension)
in the suspension of the one-step CLA-coated Fe3O4 NPs, both washed
(Fe3O4 + CLA1-TS) and not washed (Fe3O4-NW+ CLA1-TS). The sus-
pension was placed in orbital shaker at 80 °C at 150 rpm for half hour.
Subsequently, NPs were washed twice with ethanol and re-suspendedin bi-distilled water, adjusting the pH at 12 by adding NH4OH drop by
drop [14].2.4. Synthesis of silica-coated magnetite nanoparticles (Fe3O4-SiO2)
In order to promote the single nanoparticles coating in a uniform
way and obtain a stable suspension, Fe3O4 NPs were stabilized with
0.05 M citric acid. The pH was adjusted to 5.2 by dropwise NH4OH and
the suspension was placed 90min at room temperature in orbital shak-
er (KS 4000i control, IKA®) at 150 rpm allowing the deprotonation of
two carboxylic groups of citric acid and the bond to the OH groups ex-
posed by Fe3O4 NPs [15]. Subsequently, citric acid-functionalized NPs
were washed with bi-distilled water using an ultrafiltration device
(Solvent Resistant Stirred Cells - Merck Millipore) and re-suspended
in bi-distilledwater, adjusting the pH at about 10.1 to induce the depro-
tonation of the third carboxylic group, which allow an optimal NP dis-
persion. Then, magnetite NPs functionalized with citric acid were
coated with a silica shell (Fe3O4-SiO2) by sol-gel method, by adding
TEOS (tetraethoxysilane) as silica precursor, ethanol as catalyst and
water as solvent, to Fe3O4 NPs suspended in a water and ethanol solu-
tion (water: ethanol 1:4) [16]. The pH of suspension was adjusted at
10 (NH4OH); the suspension was placed in orbital shaker at room tem-
perature for 3 h at 150 rpm. Subsequently, the Fe3O4-SiO2 NPs were
washed with bi-distilled water using an ultrafiltration device (Solvent
Resistant Stirred Cells - Merck Millipore) and re-dispersed in water.2.5. One-step synthesis of conjugated linoleic acid-capped Fe3O4-SiO2
On the base of the results obtained for CLA coated Fe3O4, Fe3O4-SiO2
were functionalized with the higher CLA amount (4.5 μl CLA/ml of NPs)
with one-step procedure (Fe3O4-SiO2 + CLA2). The suspension was
heated at 80 °C and stirred at 150 rpm for half hour. At the end of the
functionalization process CLA capped Fe3O4-SiO2 NPs were washed
twice with ethanol and re-suspended in bi-distilled water.
Table 1 resumes the name and samples composition. All chemicals
were purchased from Sigma-Aldrich Co. (St Louis, MO, USA).2.6. Nanoparticles characterization
All synthesized NPs were subjected to morphological characteriza-
tion by scanning transmission electron microscopy (STEM, MERLIN
Zeiss – Germany). For STEM observation, a drop of diluted NP suspen-
sion was deposited on a copper TEM grid with carbon film (SPI Sup-
plies® Brand Lacey Carbon Coated 200 Mesh Copper Grids – JEOL
S.p.A.). Fourier transformation infrared spectroscopy (FT-IR) was used
to evidence the effective grafting of CLA and to confirm the presence
of silica shell. FT-IR spectra were acquired in a Hyperion 2000 FT/IR
(Tensor 27, Bruker Optics S.p.A, Ettlingen, Germany) from 4000 to
400 cm−1 and with 2 cm−1 resolution. OPUS software (v. 6.5, Bruker
S.p.A) was used for instrumental control and spectral acquisition. Sus-
pension stability and dispersion were evaluated in a semi-quantitative
way by measuring the time required for particle precipitation.
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or with CLA alone, and of MS1 cells with Fe3O4 NPs capped or not with CLA
Mouse breast cancer 4T1 cells were seeded (12,500 cells/cm2) in
DMEM/F-12 medium supplemented with 2 mM glutamine, 1% (v/v)
antibiotic/antimycotic solution, 10% (v/v) fetal bovine serum (FBS)
and maintained at 37 °C in a humidified atmosphere of 5% CO2
in air. Mouse pancreatic islet endothelial MS1 cells were seeded
(12,500 cells/cm2) inDMEMmedium supplementedwith 1%glutamine,
1% (v/v) antibiotic solution, 10% (v/v) fetal bovine serum(FBS). Both cell
lines were maintained at 37 °C in a humidified atmosphere of 5% CO2 in
air and 24 h after seeding, culture medium was removed and replaced
by the same medium not supplemented or supplemented with Fe3O4,
Fe3O4-SiO2, Fe3O4 + CLA1, Fe3O4-NW + CLA1, Fe3O4 + CLA1-TS,
Fe3O4-NW + CLA1-TS, Fe3O4 + CLA2 and Fe3O4-SiO2 + CLA2 at the
concentrations 8 μg or 16 μg of NPs/100,000 cells. Twenty-four hours
after seeding, the 4T1 cells were also treated with CLA alone at 10 and
25 μM concentrations. The experimental times were 24, 48 and 72 h.
2.7.1. Cell viability
Cell viability was evaluated by means of the MTT assay after 24,
48 and 72 h of treatment. 4T1 or MS1 cells grown in multiwells were
added with 30 μl of 4.5-dimethylthiazol-2-yl-,5-diphenyltetrazolium
bromide (MTT, 5 mg/ml) in PBS solution, and incubated for 3 h at 37 °C
in a humidified atmosphere of 5% CO2 in air. After the supernatants
were removed and 150 μl of DMSO was added to each well. After
20 min of incubation, the absorbance was measured at 590 nm using a
microplate reader (Dynatech MR580 microElisa, USA).
2.7.2. Iron staining
After 24 and 72 h of treatment in chamber slides, the iron stain KIT
HT20 (Sigma-Aldrich Co., St Louis, MO, USA) was used to evidence the
SPIONs functionalized or not with CLA internalized by 4T1 and MS1
cells.
2.7.3. CLA percentage content in incubated cells
As indication of CLA-capped NP internalization, the CLA percentage
contentwas determined in lipids extracted from6×106 cells previously
incubated with Fe3O4, Fe3O4 + CLA1, Fe3O4 + CLA2 or Fe3O4-SiO2
+ CLA2 NPs for 72 h. After treatment, the cells were washed with PBS
+EDTA (0.53mM), detachedwith trypsin/EDTA (0.25%/0.3%), and cen-
trifuged at 600 g for 10 min at 4 °C.
Lipids, isolated by Folch et al. method [17], were suspended in 0.5ml
of methanol containing internal standard 1,2-dihenarachidoyl-sn-
glycero-phosphocholine. The method of Klem et al. [18] for analysis of
red blood cell fatty acid compositionwas adapted for the determination
of CLA in 4T1 cell lipids. The extracts were evaporated under nitrogen
flow, dissolved with chilled methanol containing 2,6 di-ter-butyl-4-
methyl-phenol (BHT) as antioxidant, treated for 15 min in an ultra-
sound bath and then centrifuged. The supernatants were treated with
a methanol solution of sodiummethoxide to synthetize CLA methyl es-
ters, and after 5min a hydrochloric acid solutionwas added. CLAmethyl
esters were extracted twice with hexane, evaporated under nitrogen
flow at 35 °C, and re-dissolved in hexane containing BHT for injection
in gas chromatograph–mass spectrometer. CLA were identified and
quantified with a mass spectrometer operating in electron impact ioni-
zation (EI) mode. The selection of ions for selective ion monitoring
(SIM) was based on comparison with standards and those reported in
the literature [19,20].
2.8. Statistical analysis
All data are expressed as means ± SD. Differences between group
means were assessed by analysis of variance followed by a post hoc
Newman–Keuls test.3. Results
3.1. Nanoparticles synthesis and characterization
The superparamagnetic properties and theXRD pattern of Fe3O4 NPs
obtained with analogue procedure have been previously assessed [21].
Fig. 1 shows STEM analyses of Fe3O4 + CLA1, Fe3O4-NW + CLA1,
Fe3O4 + CLA1-TS, Fe3O4-NW + CLA1-TS, Fe3O4 + CLA2 and Fe3O4-
SiO2 + CLA2 NPs. All NPs present a spherical shape with a dimensional
range of about 5–15 nm, with the exception of silica coated NPs, seem-
ing slightly bigger (up to 20 nm). A silica shell (of about 1–2 nm) is well
visible in the micrograph (last panel of Fig. 1) and is evidenced by
arrows.
FT-IR spectra of pure CLA, Fe3O4 + CLA1, Fe3O4-NW + CLA1,
Fe3O4 + CLA1-TS, Fe3O4-NW+ CLA1-TS are reported in Fig. 2. Fig. 2a
shows the spectrum of CLA, in which two peaks at about 2852 e
2922 cm−1 are assigned respectively to the asymmetric and symmetric
stretching of CH2; the peak at about 1710 cm−1 can be attributed to the
C_O stretch vibration, thepeak at 1460 cm−1 to the\\COO− asymmet-
ric stretch vibration [14], the peak at 1408 to the “umbrella” bending
mode of CH3 group [14], the band between 1250 and 1285 cm−1 can
be associated to the presence of the C\\O stretch or more generally to
the vibration of the COOH group in oleic acid [22,23], the peaks at 981
and 945 cm−1 are characteristic of the cis,trans conjugated dienes [24]
and the peak at about 720 cm−1 can be assigned both to CH2 bending
or rocking vibration and CH_CH vibration [24,23]. No significant differ-
ences can be observed in the FT-IR spectrumof pure CLA treated at 80 °C
(not reported), as a confirmation that the functionalization procedure
does not alter the molecule. Fig. 2b shows the whole spectrum for all
NPs, showing peaks at about 560 cm−1, ascribable to Fe\\O stretching
vibrational mode of Fe3O4, peaks at about 2852 e 2922 cm−1 that can
be assigned respectively to the asymmetric and symmetric stretching
of CH2 group of CLA, and a peak at about 1408 cm−1 which can be as-
cribed to the “umbrella” bending mode of CH3 group [14]. Focusing
the analysis between 1000 and 4000 cm−1 (Fig. 2c), it is possible to no-
tice also the presence of a broad band at about 1500–1640 cm−1 that
can be attributed to the asymmetric and symmetric stretch vibration
of COO− group reported in literature for fatty acids adsorbed on Fe3O4
[14,22]. Moreover, in the Fe3O4 + CLA1-TS and Fe3O4-NW+ CLA1-TS
curves, the band at about 1250–1285 cm−1 and the peak at about
1710 cm−1 appeared (the first one ascribed to the C\\O stretch vibra-
tion, or to the vibration of the COOH group in oleic acid [22,23], the sec-
ond one to the C_O stretch vibration [14]).
The FT-IR spectra of Fe3O4+CLA2 and Fe3O4-SiO2+CLA2NPs are re-
ported in Fig. 3. The silica presence is evidenced by: a new peak at about
1060 cm−1, attributed to the asymmetric stretching of the Si\\O\\Si
group, two peaks at 960 and 780 cm−1, attributed Si\\OH stretching vi-
bration and Si\\O\\Si symmetric stretching [25,26], and a band at
about 3000–3300 cm−1, ascribable to OH groups. The peaks at 2852 e
2922 cm−1 can be assigned respectively to the asymmetric and symmet-
ric stretching of CH2 group of CLA, the band at about 1500–1640 cm−1, at-
tributed to the asymmetric and symmetric stretch vibration of adsorbed
COO− group [14,22], and the peak at about 1408 cm−1 ascribed to the
“umbrella” bending mode of CH3 group. Also in this samples the peak at
about 1710 cm−1, ascribable to the C_O vibration of CLA, appears.
Fig. 4 reports the behavior of the various NP suspensions after
different times of sedimentation. The precipitation of Fe3O4 + CLA1
NPs starts after 5 min and is already complete after 30 min. The
Fe3O4 + CLA2 and Fe3O4-SiO2 + CLA2 solutions are both still stable
after 2 h, and only Fe3O4-SiO2 + CLA2 also after 24 h.
3.2. The effect of SPIONs and CLA alone on mouse breast cancer 4T1 cells
and on mouse pancreatic islet endothelial MS1 cells
SPIONs, washed or not, and SPIONs functionalized with CLA (low and
high amount, one- or two-steps) were tested to choose the preparation
Fig. 1. STEM images of SPIONs. Fe3O4 + CLA1, washed CLA-capped Fe3O4 NPs; Fe3O4-NW+ CLA1, not washed CLA-capped Fe3O4 NPs; Fe3O4 + CLA1-TS, washed two step CLA-capped
Fe3O4 NPs; Fe3O4-NW+ CLA1-TS NPs, not washed two step CLA-capped Fe3O4 NPs; Fe3O4 + CLA2; Fe3O4-SiO2 + CLA2, silica shell-coated, washed CLA-capped Fe3O4 NPs. CLA1, 3.0 μl
of CLA/ml of NPs; CLA2, 4.5 μl of CLA/ml of NPs.
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particles decrease cell number in comparisonwith SPIONs not functional-
ized with CLA (Fe3O4), being the major inhibition obtained by SPIONs
washed and capped with CLA with one-step procedure (data notFig. 2. FT-IR spectra. (a) FT-IR spectra of pure CLA; (b) whole spectrum of Fe3O4-NW + CLA1
(curve IV) NPs; (c) selected windows between 1000 and 4000 cm−1. See legend in Fig. 1 for Nshown). Therefore, in the following experiments, only Fe3O4, Fe3O4 +
CLA1 and Fe3O4 + CLA2, with or without silica shell, were compared.
Fig. 5 shows the percentages of viability in cells treated with various
SPIONs in comparisonwith the control cells, set to 100%. The viability in(curve I), Fe3O4-NW+ CLA1-TS (curve II), Fe3O4 + CLA1 (curve III), Fe3O4 + CLA1-TS
P acronyms.
Fig. 3. FT-IR spectra. FT-IR spectra of Fe3O4 + CLA2 (curve I) and Fe3O4-SiO2 + CLA2
(curve II) NPs. See legend in Fig. 1 for NP acronyms.
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is lower than in control cells and in cells treated with Fe3O4 and
Fe3O4-SiO2.
When the cells were treated with SPIONs coated or not with silica
and capped or not with CLA, the reduction of viability is higher in cells
treated with Fe3O4 + CLA2 than in the cells treated with other ones.
No significant difference was found between 48 and 72 h for cells treat-
ed with SPIONs + CLA for both quantity of NPs. The NP internalization
by cells was evidenced with iron staining (Fig. 6). NPs functionalized
or not with CLA are present in the cells, whereas no staining is evident
in cells untreated with NPs. The analysis by gas chromatography-massFig. 4. Precipitation of SPIONs. Time of precipitation of NPs with or witspectrometry of lipids extracted from 4T1 cells incubated with
SPIONs coated or not with silica and capped or not with CLA shows
that CLA is incorporated in lipids, and it is higher in cells treated with
Fe3O4 + CLA2 in comparison with cells treated with Fe3O4 + CLA1
NPs (Table 2). With regards the incorporation of CLA in lipids extracted
from 4T1 cells incubated with Fe3O4-SiO2+ CLA2, the Table 2 showed a
lesser incorporation of CLA for isomer 1 and 2 and a slight increase for
the isomer 3.
The effect of CLA alone on 4T1 cell viability is reported in Table 3.
Two concentrations of CLA similar to the quantity used for the prepara-
tion of SPIONswere added to the 4T1 cells. A time-dependent reduction
of cell viability was observed.
To verify whether the different types of SPIONs affected in different
way normal and cancer cells, pancreatic islet endothelial MS1 cells were
treated. For these experiments, only CLA2 (4.5 μl CLA/ml of NPs) was
used. Table 4 shows that no decrease of viability was induced by all
types of SPIONs in comparison with control cells. In particular there
were no differences between SPIONs capped or not with CLA.
Fig. 7 reports that NPs coated or not with silica and capped or not
with CLA are present in the MS1 cells.
Prussian blue staining was used to evidence the presence of SPIONs
with andwithout silica capped or not with CLA in pancreatic islet endo-
thelial MS1 cells. As shown in the panels, all the SPIONs highly interact
withMS1 cells, with the exception of silica coatedwith CLA, that are less
internalized in cells. It was reported only the iron staining relative to 16
μg/100,000 cells of various SPIONs after 24 h of treatment. See Table 1
for NP acronyms.
4. Discussion
In recent years, NPs have been proposed for biomedical utilization
[27–31]. This approach implies the synthesis of biocompatible NPs,
which are also stable and easily manageable in biological media. Forhout silica, capped or not with CLA. See Table 1 for NPs acronyms.
Fig. 5.Viability ofmouse breast cancer 4T1 cells exposed to Fe3O4NPs coated or notwith silica and cappedor notwith CLA. The values aremeans±S.D. of 4 experiments and are expressed
as % of control cells set equal to 100%. The absorbance values of control are 0.591 ± 0.192 for 24 h, 1.457 ± 0.151 for 48 h and 1.596 ± 0.168 for 72 h. For each NP quantity (8 or 16 μg),
means with different letters are significantly different from one another (p b 0.05) as determined by analysis of variance followed by a post-hoc Newman-Keuls test. See Table 1 for NPs
acronyms. C, control cells (black line); 8 μg, 16 μg, were the quantity of various NPs added to 100,000 cells.
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stability, prevent oxidation, and improve biocompatibility of NPs [10].
Among them, fatty acids have been also investigated.
Some authors have used OA, which belongs to unsaturated
monocarboxylic acids, to functionalize Fe3O4 NPs; in particular the
study reported by Hemei Chen et al. [32] showed that OA capped
Fe3O4 NPs possessed high magnetization and were useful to further
adsorb other biomacromolecules. Other studies, instead of using a
single adsorption layer of OA, stabilized magnetic NPs by short-chain-
length monocarboxylic acids, such as lauric acid and myristic acid
[33], but themagnetic NPswere in part aggregated [34]. However, mag-
netic NPs coated with myristic or lauric acids were cytotoxic for glio-
blastoma cells, showing low toxicity for normal astrocytes [33].
Starting from the evidence that fatty acids seem biocompatible for
healthy cells and toxic for cancer cells, the rationale of their use as cap-
ping agent formagnetic NPs should be adjusted, trying to optimize their
role as NPs driven therapeutic agents, not only as biocompatible
surfactants.Fig. 6. Iron staining. Prussian blue stainingwasused to evidence thepresence of SPIONswith and
only the iron staining relative to 16 μg/100,000 cells of various SPIONs after 72 h of treatment.In this study, CLA was chosen as capping agent for magnetic NPs for
its antitumor properties [11–13]; its effect on colloidal stability of NPs
suspensions and its potential therapeutic effect, when grafted on NPs,
were evaluated. The effect of silica coating was also investigated. The
superparamagnetic properties of pure Fe3O4 NPs were previously
assessed [21]. The size and morphology of the NP batch prepared for
this researchwere investigated and a good reproducibility of the results
was observed in respect of previous preparations, both for uncoated and
silica coated magnetic NPs. The presence of CLA on the magnetic NPs
was evidenced by the FT-IR analysis. The results showed the presence
of iron oxide and of organic species ascribable to CLA on all samples. It
can therefore be assumed that all the functionalization methods were
successful. Interestingly it can be evidenced that different signals ascrib-
able to CLA, which could be related to the presence of a single- or bi-lay-
ered configuration, were present. All functionalized particles showed
the signals related to the CLA main chain (2852 e 2922 cm−1 of CH2
group and 1408 cm−1 of CH3 group [14]). Moreover, in all functional-
ized NPs also the band ascribed to asymmetric and symmetric stretchwithout silica cappedor notwith CLA in themouse breast cancer 4T1 cells. Itwas reported
C, control cells without SPIONs; see Table 1 for NPs acronyms.
Table 2
Conjugated linoleic acid (CLA) in lipids extracted from 4T1 cells treated for 72 h with
SPIONs coated or not with silica and capped or not with CLA. The values are means of
two experiments and are expressed as number of times the control cells (C) set equal to
1. See legend in Table 1 for NPs acronyms. 16 μg were the quantity of NPs added to
100,000 cells.
Sample CLA: 3 isomers
Isomer n. 1 Isomer n. 2 Isomer n. 3
C 1 1 1
Fe3O4 16 μg 0.90 0.72 0.68
Fe3O4 + CLA1 16 μg 1.97 15.30 1.08
Fe3O4 + CLA2 16 μg 2.75 19.70 1.26
Fe3O4-SiO2 + CLA2 16 μg 1.52 1.64 1.61
Table 4
Viability of pancreatic islet endothelial MS1 cells exposed to Fe3O4 NPs coated or not with
silica and capped or not with CLA. The values are means of 2 experiments and are
expressed as % of control cells set equal to 100%. The absorbance values of control are
0.256 for 24 h, 0.771 for 48 h and 0.601 for 72 h.
Sample 24 h 48 h 72 h
8 μg 16 μg 8 μg 16 μg 8 μg 16 μg
C 100 100 100 100 100 100
Fe3O4 97.09 103.41 111.47 103.24 151.99 140.76
Fe3O4 + CLA2 94.80 104.86 125.76 103.63 146.53 133.11
Fe3O4-SiO2 101.56 110.86 114.02 107.13 127.03 131.44
Fe3O4-SiO2 + CLA2 102.94 114.79 118.96 94.16 136.76 148.91
See Table 1 for NPs acronyms. C, control cells; 8 μg, 16 μg, were the quantity of various NPs
added to 100,000 cells.
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band was not present in the FT-IR spectrum of pure CLA (i.e. not
adsorbed on any support) since it can be related to the covalent interac-
tion between COO− groups and Fe atoms in a chelating bidentate inter-
action with iron oxide surfaces [22]. The patterns of the Fe3O4 + CLA1-
TS and Fe3O4-NW + CLA1-TS revealed signals also present in not
adsorbed CLA (1250–1285 cm−1 for C\\O [22,23] and 1710 cm−1
C_O [14]), but absent in the patterns of CLA adsorbed on NPs with a
single-step procedure and low CLA content (see for example the pat-
terns of Fe3O4+CLA1, Fe3O4-NW+CLA1 and [23]), as a demonstration
of the presence of free\\COOH groups exposed on the NP surface,
typical of a bi-layer configuration [14]. The functionalization with
highest CLA amount, even in a single step (Fe3O4 + CLA2 and
Fe3O4-SiO2 + CLA2), gave FT-IR results similar to Fe3O4 + CLA1-TS
and Fe3O4-NW + CLA1-TS NPs both with and without the presence of
silica shell. In this case the excess of CLA probably produced a secondary
layer, with a configuration similar to the one obtained by the two-step
synthesis procedure [14].
The NPs functionalized with CLA in a one step were chosen,
among different preparations of SPIONs, because they reduced cell via-
bility more than NPs coated with CLA with two-step procedure (data
not shown). Two amounts of CLA (one step) were used: Fe3O4 + CLA1
(3 μl CLA/ml of NPs) and Fe3O4+CLA2 (4.5 μl of CLA/ml of NPs). The re-
sults obtained showed that both Fe3O4 + CLA1 and Fe3O4 + CLA2 re-
duced the cell viability of 4 T1 cells treated for 24 and 72 h, respect to
control cells not incubated with SPIONs and to 4 T1 cells incubated
with SPIONs without CLA, but Fe3O4 + CLA2 was more effective in the
reduction than Fe3O4 + CLA1. For Fe3O4 + CLA2, the viability values
were not significantly different between 48 and 72 h. A similar trend
was observed in 4 T1 cells treated with CLA alone.
To be highlighted that the experiments, carried out to evaluate the
effect of various SPIONs on normal cells, showed that SPIONs capped
or not with CLA2 and coated or not with silica did not decrease the via-
bility of the normal MS1 cells.
The NP precipitation time with both CLA amounts was also deter-
mined. Although all the particles seem aggregated in STEM images of
Fig. 1 suspensions stable up to 24 h were obtained (Fig. 4), as discussed
below. This observation may be explained by the fact that STEM images
of the particles were obtained after drying a drop (5 μl) of the suspen-
sion onto a carbon coated copper TEM grid. Upon drying onto aTable 3
Viability of mouse breast cancer 4T1 cells exposed to CLA.
Sample 24 h 48 h 72 h
C 100 100 100
CLA 10 μM 91.7 69.1 72.0
CLA 25 μM 86.5 69.2 69.5
The values are means of 2 experiments and are expressed as % of control cells set equal to
100%. The absorbance values of control are 0.591± 0.192 for 24 h, 1.457± 0.151 for 48 h
and 1.596 ± 0.168 for 72 h.
C, control cells.substrate particles obviously aggregates and appear as agglomerates
in the images.
As shown in Fig. 4 the precipitation timewas shorter for Fe3O4+CLA1
than for Fe3O4+CLA2: at 30min Fe3O4+CLA1NPswere all precipitated,
while Fe3O4+CLA2NPs remained in suspension up to 2h. This difference
can be explained taking into account that Fe3O4 + CLA2, even if synthe-
sized with one step procedure, were covered by a secondary layer of
CLA (see FT-IR results). It can be supposed that the highest amount
of CLA caused a condition similar to that of bilayer-coated NPs
(even if the bilayer was probably not continuous). It is reasonable
that Fe3O4 + CLA2 NP surface is more hydrophilic in comparison to
that of Fe3O4 + CLA1 ones (which do not expose free \\COOH
groups) and, in turn, NPs show a better stability in aqueous medium.
The determination, by gas chromatography-mass spectrophotome-
try, of CLA isomers in the lipids extracted from cells incubated with
SPIONs functionalized or not with CLA, showed that this fatty acid was
more incorporated in the cells treated with Fe3O4 + CLA2 NPs than in
the cells treated with Fe3O4 + CLA1 NPs. The results of this study indi-
cate that the use of the highest amount of CLA (4.5 μl/1 ml of NPs) im-
proves the suspension stability, the CLA incorporation into the cells
and the antitumor activity. It worth of mentioning that it is very impor-
tant to avoid the formation of clusters, because they partially lose the
magnetic properties, and, when injected intravascularly, show a shorter
circulation time due to rapid clearance by monocytes, this decreasing
the reaching of target cells or tissues.
Interestingly the NPs coated with a thin layer of silica and function-
alized with CLA showed a further increase of time required to have
the precipitation, in fact at 24 h Fe3O4-SiO2 + CLA2 NPs were all dis-
persed in solution. This effect can be mainly attributed to the citric
acid functionalization needed for silica coating, and cannot be ascribed
exclusively to CLA amount. Fe3O4-SiO2 + CLA2 NPs also cause a reduc-
tion of cell viability in comparison with control cells and CLA-free
Fe3O4-SiO2, but the inhibition was lower than that obtained with
Fe3O4 + CLA2. In the same way, the incorporation of CLA in lipid ex-
tracted from the cells treated with Fe3O4-SiO2 + CLA2 NPs was lower
for the isomers 1 and 2 than that obtained with Fe3O4 + CLA2.
This difference could be ascribed to the role of the silica shell
avoiding the direct contact between the magnetite NPs and the biolog-
ical environment, which in turn reduces their potential toxicity.
Moreover, according to the reported data, we can infer that fatty
acids may improve the affinity between NPs and cell membrane and
favor particle internalization in tumor cells. This is an important issue
for future research, for example for studies with other cancer cell lines
as well as for magnetic NP-assisted gene therapy, to improve the use
of viral vectors to transfer therapeutic genes to target cells [35–37].
5. Conclusions
In this research colloidal suspensions of Fe3O4 NPs, both uncoated or
coated by silica shell, of about 5–20 nm in diameter, were successfully
prepared and functionalized with different amounts of CLA both in
Fig. 7. Iron staining for MS1 cells.
446 G. Muzio et al. / Materials Science and Engineering C 76 (2017) 439–447single- and bi-layer configurations. Both the silica shell and CLA layer
played a role in determining suspension stability, especially when CLA
was grafted on the NP surface in a bi-layer configuration. The results ev-
idenced that the viability of mouse breast cancer 4T1 cells was reduced
in presence of Fe3O4 NPs functionalized with CLA in comparison with
both untreated control cells and cells treated with CLA-free NPs. The
presence of the silica coating in CLA capped NPs caused a lesser inhibi-
tion of cell viability. Since it is known that the colloidal stability must
be assured to avoid uncontrolled NPs clusterization, loosening of mag-
netic properties and short circulation time, control of this parameter is
crucial, even if it is not directly related to the antitumoral effect ob-
served in this work. Based on these results, silica shell free Fe3O4 NPs
functionalizedwith high amount of CLA (with bi-layered configuration)
can be suggested as therapeutic carriers for their good dispersion and
ability to decrease mouse breast cancer 4T1 cell viability.Acknowledgments
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